The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma ; volume:14 ; number:1 ; day:20 ; month:7 ; year:2023 ; pages:1-15 ; date:12.2023
Nature Communications ; 14, Heft 1 (20.7.2023), 1-15, 12.2023
- Urheber
-
Smith, Philip
Bradley, Thomas
Gavarró, Lena Morrill
Goranova, Teodora
Ennis, Darren P.
Mirza, Hasan B.
Silva, Dilrini De
Piskorz, Anna M.
Sauer, Carolin M.
Al-Khalidi, Sarwah
Funingana, Ionut-Gabriel
Reinius, Marika A. V.
Giannone, Gaia
Lewsley, Liz-Anne
Stobo, Jamie
McQueen, John
Bryson, Gareth
Eldridge, Matthew
Macintyre, Geoff
Markowetz, Florian
Brenton, James D.
McNeish, Iain A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-39867-7
- URN
-
urn:nbn:de:101:1-2024020210521256339760
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smith, Philip
- Bradley, Thomas
- Gavarró, Lena Morrill
- Goranova, Teodora
- Ennis, Darren P.
- Mirza, Hasan B.
- Silva, Dilrini De
- Piskorz, Anna M.
- Sauer, Carolin M.
- Al-Khalidi, Sarwah
- Funingana, Ionut-Gabriel
- Reinius, Marika A. V.
- Giannone, Gaia
- Lewsley, Liz-Anne
- Stobo, Jamie
- McQueen, John
- Bryson, Gareth
- Eldridge, Matthew
- Macintyre, Geoff
- Markowetz, Florian
- Brenton, James D.
- McNeish, Iain A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Principles of dormancy evident in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Principles of dormancy evident in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Principles of dormancy evident in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer